NOG outlines $1.4B-$1.5B 2026 adjusted EBITDA outlook while lifting buyback capacity to $243M

Pain drug developer Latigo climbs after upsized IPO

2026/08/07

B2Gold granted Fekola Regional exploitation permit by Mali government

2026/08/07

Weave anticipates $273M-$275M 2026 revenue while raising operating income outlook to $12M-$14M

2026/08/07

LunR Royalties reports Q2 results

2026/08/07